Beryl Drugs Ltd
Beryl Drugs | 524606
Share Price Chart - Beryl Drugs Ltd
Stock Performance
Ratios
Consolidated data not available
Please try selecting a different data type
About Company
- Beryl Drugs Limited was incorporated on August 24, 1993
- The Company acquired the running business of M/s Flora and Fauna Remedies Limited on December 15, 1993
- The Shares of Company were listed on M
- Stock Exchange, Bombay Stock Exchange and Ahmedabad Stock Exchange
- The Company thereafter has been engaged in the manufacture, sale, and export of branded, generic pharmaceutical formulations in India and internationally
- fluids, and a range of small and large volume injectables
- It provides a range of eye/ear drops, veterinary products, and injections
- It sells products through sales and distribution network
- In addition, it offers research and development, as well as contract manufacturing services
- is based in Indore, India
Research Calls
Technical Indicators
Pivot Points
No Information Available
Volume Analysis data is not available at this time.
No Information Available
Growth Rate information is not available at this time.
All figures in ₹ Crores
No Information Available
No profit & lossdata available
No Information Available
No shareholding data available at this time.
No Data Available
No Block Deals data available for this company.
News
No Information Available
Peers
#IndiaInvests
Trusted by 2.5 lac + Indians for their wealth-building needs
Invest in stocks with ease
Open your account in less than 10 mins*
By proceeding, you agree to all T&C *
Top Gainers
Frequently Asked Questions
What is Share Price of Beryl Drugs Ltd?
The current share price of Beryl Drugs Ltd (Beryl Drugs) is ₹24.42. This price reflects the latest market valuation and is updated in real-time during trading hours.
What is the 52-week high and low of Beryl Drugs Ltd?
Beryl Drugs Ltd has a 52-week high of ₹30.00 and a 52-week low of ₹15.92. This range shows the stock's price volatility over the past year.
What is the ROE of Beryl Drugs Ltd?
Beryl Drugs Ltd has a Return on Equity (ROE) of 6.30%. ROE measures how effectively the company uses shareholders' equity to generate profits, with higher values generally indicating better performance.
Disclaimer:
Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.
